(Q28181097)

1

0 references

Mainak Majumder

2

0 references

Robert Steele

3

0 references

Ranjit Ray

Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome

4

0 references

language of work or name

English

0 references

publication date

1 February 2003

0 references

published in

Virology

0 references

volume

306

0 references

issue

1

0 references

page(s)

51-9

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900029-6

7 January 2021

Characterization of the interferon regulatory factor-7 and its potential role in the transcription activation of interferon A genes

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900029-6

7 January 2021

In vitro models for hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900029-6

7 January 2021

Mx genes show weaker primary response to virus than other interferon-regulated genes

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900029-6

7 January 2021

DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900029-6

7 January 2021

Efficient initiation of HCV RNA replication in cell culture

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900029-6

7 January 2021

Interferon alfa subtypes and levels of type I interferons in the liver and peripheral mononuclear cells in patients with chronic hepatitis C and controls

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900029-6

7 January 2021

Alpha Interferon Inhibits Hepatitis C Virus Replication in Primary Human Hepatocytes Infected In Vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900029-6

7 January 2021

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900029-6

7 January 2021

Hepatitis C virus replication is directly inhibited by IFN-alpha in a full-length binary expression system

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900029-6

7 January 2021

AP-1 and Oct-1 transcription factors down-regulate the expression of the human PIT1/GHF1 gene

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900029-6

7 January 2021

Hepatitis C and hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900029-6

7 January 2021

Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900029-6

7 January 2021

Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900029-6

7 January 2021

Activation of the interferon-beta promoter during hepatitis C virus RNA replication.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900029-6

7 January 2021

Hepatitis C virus NS5A protein modulates transcription through a novel cellular transcription factor SRCAP

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900029-6

7 January 2021

Hepatitis C virus NS5A protein protects against TNF-alpha mediated apoptotic cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900029-6

7 January 2021

Hepatitis C virus NS5A protein modulates cell cycle regulatory genes and promotes cell growth

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900029-6

7 January 2021

Effect of alpha interferon on the hepatitis C virus replicon

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900029-6

7 January 2021

Hepatitis C virus and hepatocarcinogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900029-6

7 January 2021

Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900029-6

7 January 2021

The treatment of chronic viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900029-6

7 January 2021

Treatment of acute hepatitis C with interferon alfa-2b

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900029-6

7 January 2021

Hepatitis C virus particle detected by immunoelectron microscopic study

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900029-6

7 January 2021

Production of two phosphoproteins from the NS5A region of the hepatitis C viral genome.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900029-6

7 January 2021

Impaired antiviral response in human hepatoma cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900029-6

7 January 2021

Hepatitis C virus IRES-dependent translation is insensitive to an eIF2alpha-independent mechanism of inhibition by interferon in hepatocyte cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900029-6

7 January 2021

Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900029-6

7 January 2021

Multiple regulatory domains control IRF-7 activity in response to virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900029-6

7 January 2021

Selective DNA binding and association with the CREB binding protein coactivator contribute to differential activation of alpha/beta interferon genes by interferon regulatory factors 3 and 7.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900029-6

7 January 2021

Repression of virus-induced interferon A promoters by homeodomain transcription factor Ptx1

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900029-6

7 January 2021

Hepatitis C virus NS5A physically associates with p53 and regulates p21/waf1 gene expression in a p53-dependent manner

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900029-6

7 January 2021

Hepatitis C virus NS5A protein impairs TNF-mediated hepatic apoptosis, but not by an anti-FAS antibody, in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900029-6

7 January 2021

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900029-6

7 January 2021

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900029-6

7 January 2021

Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900029-6

7 January 2021

Enhanced expression of interferon-regulated genes in the liver of patients with chronic hepatitis C virus infection: detection by suppression-subtractive hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900029-6

7 January 2021

Evolution of hepatitis C virus quasispecies in hypervariable region 1 and the putative interferon sensitivity-determining region during interferon therapy and natural infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900029-6

7 January 2021

NeuroD1/beta2 contributes to cell-specific transcription of the proopiomelanocortin gene

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900029-6

7 January 2021

Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900029-6

7 January 2021

Early hepatitis C viral kinetics correlate with long-term outcome in patients receiving high dose induction followed by combination interferon and ribavirin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900029-6

7 January 2021

Hepatitis C virus infection is associated with the development of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900029-6

7 January 2021

Relationship of hepatitis C genotype 1 NS5A sequence mutations to early phase viral kinetics and interferon effectiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900029-6

7 January 2021

Expression of the human MxA protein is associated with hyperphosphorylation of VSV P protein in human neural Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900029-6

7 January 2021

Viruses and interferons

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900029-6

7 January 2021

Identification of distinct signaling pathways leading to the phosphorylation of interferon regulatory factor 3

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900029-6

7 January 2021

P-OTX: a PIT-1-interacting homeodomain factor expressed during anterior pituitary gland development

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900029-6

7 January 2021

How hepatitis C virus counteracts the interferon response: the jury is still out on NS5A.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900029-6

7 January 2021

Egr-1 is a downstream effector of GnRH and synergizes by direct interaction with Ptx1 and SF-1 to enhance luteinizing hormone beta gene transcription

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900029-6

7 January 2021

Ptx1 regulates SF-1 activity by an interaction that mimics the role of the ligand-binding domain

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900029-6

7 January 2021

Transcriptional properties of Ptx1 and Ptx2 isoforms

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900029-6

7 January 2021

Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900029-6

7 January 2021

Current and evolving therapies for hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900029-6

7 January 2021

Phosphorylation of the hepatitis C virus NS5A protein in vitro and in vivo: properties of the NS5A-associated kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900029-6

7 January 2021